Market Updates

Europe Earnings: AstraZeneca, BAE, Deutsche Bank, G4S, Uralkaliy

Nigel Thomas
20 Dec, 2013
New York City

    AstraZeneca agreed to buy diabetes-treatment business from Bristol-Myers for $4.1 billion. BAE confirmed

[R]3:40 PM Frankfurt – AstraZeneca agreed to buy diabetes-treatment business from Bristol-Myers for $4.1 billion. BAE confirmed £6 billion deal for 60 Euro-fighter with UAE has not concluded. Deutsche Bank agreed to pay $1.9 billion to settle the mortgage-backed securities claims.[/R]

In London trading, FTSE 100 index gained 0.4% or 25.81 to 6,611 and in Frankfurt the DAX index jumped 0.6% or 59.80 to 9,396.

In Paris, CAC 40 index rose 0.2% or 10.59 to 4,188.

AstraZeneca Plc increased 0.6% to 3,621.50 pence after the U.K.-based biopharmaceutical company agreed to acquire diabetes-treatment business of U.S.-based Bristol-Myers Squibb for up to $4.1 billion.

BAE Systems Plc declined 4.5% to 421.81 pence after the U.K.-based aerospace and defense group said the agreement of £6 billion or $9.8 billion deal with United Arab Emirates for 60 Euro-fighter Typhoon has not been finalized.

Deutsche Bank AG gained 1.2% to €33.94 after the investment bank agree to pay €1.4 billion or $1.9 billion to settle the claims for not submitting adequate disclosure of mortgage-backed securities sold to Fannie Mae and Freddie Mac before the onset of financial crisis.

G4S Plc rose 0.04% to 249 pence and the U.K.-based security service provider faces new fraud investigations from regulators for second time in six months.

The government said Serco agreed to refund £68.5 million pounds or $110 million on its tagging contract but G4S had not yet agreed a position on repayment.

Uralkaliy OAO jumped 2.7% to 175.44 ruble after the Russia-based chemical maker said revenue in the third-quarter ending in September declined 19% to $856 million from $1.06 billion a year ago period.

Uralkali and Sberbank OJSC signed an agreement to open a non-revolving $2 billion credit line to use as a reserve facility for refinancing existing loans according to their repayment schedules.

Annual Returns

Company Ticker 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

Earnings

Company Ticker 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008